Apart from hematology malignancies, BCL3 has been shown to be participated in progression of diverse solid tumors, such as breast cancer [15], renal-cell carcinoma [13], non-small-cell lung cancer [12], cervical cancer [11], colorectal cancer [23]. The gene discussed is BCL3; the disease is non-small cell lung carcinoma.